生物等效性
化学
色谱法
蛋白质沉淀
甲酸
人血浆
洗脱
交叉研究
线性范围
基质(化学分析)
药代动力学
乙腈
准确度和精密度
分析化学(期刊)
梯度洗脱
高效液相色谱法
降水
检出限
作者
Qi Wen,Juan Cai,Min Yang,Xin‐ying Xu,Bo‐ping Wei,Qiang Wu,Dai‐guo Zhao
摘要
ABSTRACT A UPLC‐MS/MS method was developed for determining apalutamide (APT) in human plasma, applied to a bioequivalence study of two tablet formulations. Plasma samples were pretreated by protein precipitation with acetonitrile using APT‐13C‐ d 3 as an internal standard. Separation was on a Waters BEH C18 column with gradient elution (0.1% formic acid in water/acetonitrile) at a flow rate of 0.50 mL/min. ESI (+) and MRM transitions were employed, with m / z 478.1 → 221.2 for APT and m / z 482.2 → 225.3 for APT‐13C‐ d 3 . A crossover bioequivalence study (single‐dose, two‐period) was conducted under fasting or fed conditions. A good linear relationship was observed over the concentration range of 6.00~1200.00 ng/mL. The intrabatch and interbatch accuracy ranged from 95.06% to 104.22% (RSD ≤ 5.05%). The recovery was not less than 102.36%, and no significant matrix effect was observed for APT and APT‐13C‐ d 3 . In both fed and fasting trials, the 90% CI for the geometric mean ratios of C max and AUC 0–72 between the test and reference formulations fell within the range of 80.00%~125.00%. This method is simple, rapid, and accurate, making it suitable for the determination of APT concentration in human plasma. Additionally, the test and reference APT tablets were demonstrated to be bioequivalent.
科研通智能强力驱动
Strongly Powered by AbleSci AI